Muneeb Faiq

Dr. Muneeb Faiq


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2016 in Frontiers in Human Neuroscience
Verified
Journal Article
Open access
PDF file
AKAshutosh Kumar
Ashutosh Kumar
HSHimashu Narayan Singh
Himashu Narayan Singh
VPVikas Pareek
Vikas Pareek
KRKhursheed Raza
Khursheed Raza
SDSubrahamanyam Dantham
Subrahamanyam Dantham
MFMuneeb Faiq
Muneeb Faiq
Owing to the reports of microcephaly as a consistent outcome in the fetuses of pregnant women infected with ZIKV in Brazil, Zika virus (ZIKV)—microcephaly etiomechanistic relationship has recently been implicated. Researchers, however, are still struggling to establish an embryological basis for this interesting causal handcuff. The present study reveals robust evidence in favor of a plausible ZIKV-microcephaly cause-effect liaison. The rationale is based on: (1) sequence homology between ZIKV genome and the response element of an early neural tube developmental marker “retinoic acid” in human DNA and (2) comprehensive similarities between the details of brain defects in ZIKV-microcephaly and retinoic acid embryopathy. Retinoic acid is considered as the earliest factor for regulating anteroposterior axis of neural tube and positioning of structures in developing brain through retinoic acid response elements (RARE) consensus sequence (5′–AGGTCA–3′) in promoter regions of retinoic acid-dependent genes. We screened genomic sequences of already reported virulent ZIKV strains (including those linked to microcephaly) and other viruses available in National Institute of Health genetic sequence database (GenBank) for the RARE consensus repeats and obtained results strongly bolstering our hypothesis that ZIKV strains associated with microcephaly may act through precipitation of dysregulation in retinoic acid-dependent genes by introducing extra stretches of RARE consensus sequence repeats in the genome of developing brain cells. Additional support to our hypothesis comes from our findings that screening of other viruses for RARE consensus sequence repeats is positive only for those known to display neurotropism and cause fetal brain defects (for which maternal-fetal transmission during developing stage may be required). The numbers of RARE sequence repeats appeared to match with the virulence of screened positive viruses. Although, bioinformatic evidence and embryological features are in favor of our hypothesis, additional studies including animal models are warranted to validate our proposition. Such studies are likely to unfold ZIKV-microcephaly association and may help in devising methods to combat it.

8 August 2016 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
MFMuneeb Faiq
Muneeb Faiq
RDRima Dada
Rima Dada
AKAshutosh Kumar
Ashutosh Kumar
DSDaman Saluja
Daman Saluja
TDTanuj Dada
Tanuj Dada
3-(4-Amino-5-mercapto-4H-1,2,4-triazol-3-yl)-2H-chromen-2-one was used as a key intermediate for the synthesis of triazolo[3,4-b][1,3,4]thiadiazines 4a-f and triazolo[4,3-b][1,2,4,5]tetrazines 8g-l, via reactions with hydrazonoyl halides 2a-f and 2g-l, respectively. Moreover the reaction of the aminomercaptotriazole derivative with phenacyl bromide and ethyl 2-chloro-3-oxobutanoate followed by coupling reaction of the products with benzenediazonium chloride yielded the corresponding products 4f and 8g respectively. The structures of all the newly synthesized heterocyclic compounds were established by considering elemental analysis, spectral data and an alternative synthetic route. The anticonvulsant and CNS depressant activities of the newly synthesized compounds were evaluated and showed excellent activities especially N-phenyl-[1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine-6-carboxamide derivatives 8j-l. Also, their structure activity relationship was clearly demonstrated and showed that the electron-donating groups enhance activities while electron-withdrawing groups decrease activities.

1 November 2020 in Medical Hypotheses
Verified
Journal Article
Closed access
MFMuneeb Faiq
Muneeb Faiq

7 April 2020 in Preprints.org
Verified
Preprint
Open access
MFMuneeb Faiq
Muneeb Faiq
AKAshutosh Kumar
Ashutosh Kumar
HSHimanshu Singh
Himanshu Singh
VPVikas Pareek
Vikas Pareek
RQRizwana Qadri
Rizwana Qadri
SPSada Pandey
Sada Pandey
The SARS-CoV-2 is a recently identified positive sense single stranded RNA virus and member of the coronavirus family of viruses. It is thought to be the etiological factor for the ongoing COVID-19 pandemic. This virus is thought to have originated from bats and acquired ability of human-to-human transmission. While SARS-CoV-2 is relatively benign, it has infected more than half a million people (as of March 29th 2020) worldwide and the number of infected people continues to rise. More than 170 countries have reported COVID-19 positive cases. With a mortality rate of less than both the previous coronavirus outbreaks, COVID-19 has (conversely) caused the death of over 33,980 (as of 29th March, 2020 at 22.00 hours EDT) people worldwide and the number is increasing. Given the enormous impact of this virus on human health and wellbeing and consequent devastating impacts on world trade, economics and quality of life, it is important to understand this virus better and get insight into its pathogenic mechanisms which will aid in devising effective measure to curb its spread and predict future pattern of its interaction with humans. Though very little is known about this SARS-CoV-2 but its mechanisms and patterns of spread can be speculated (with caution, nevertheless) from what we know about its closest relatives SARS-CoV-1 (responsible for SARS-2002 epidemic) and MERS-CoV (responsible for MERS-2012 epidemic). In the present review, we aim at bringing together the coherent and peer reviewed literature about the SARS-CoV-2 and its close relatives and try to understand its infection patterns and reconstruct its pathogenic mechanisms with anecdotes on diagnosis and future directions. We hope that this paper will serve the purpose of being a reliable source of information to scientists, clinicians and general public.

25 December 2024 in Vision Research
Verified
Journal Article
Closed access
MFMuneeb Faiq
Muneeb Faiq
HSHimanshu N. Singh
Himanshu N. Singh
MAMashooq Ali
Mashooq Ali
RDRima Dada
Rima Dada
KCKevin C. Chan
Kevin C. Chan
DSDaman Saluja
Daman Saluja

15 April 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
AKAshutosh Kumar
Ashutosh Kumar
MFMuneeb Faiq
Muneeb Faiq
VPVikas Pareek
Vikas Pareek
KRKhursheed Raza
Khursheed Raza
RNRavi K. Narayan
Ravi K. Narayan
SKSantosh Kumar
Santosh Kumar
Introduction: COVID-19 is caused by a new strain of coronavirus called SARS-coronavirus-2 (SARS-CoV-2), which is a positive sense single strand RNA virus. In humans, it binds to angiotensin converting enzyme 2 (ACE2) with the help a structural protein on its surface called the S-spike. Further, cleavage of the viral spike protein (S) by the proteases like transmembrane serine protease 2 (TMPRSS2) or Cathepsin L (CTSL) is essential to effectuate host cell membrane fusion and virus infectivity. COVID-19 poses intriguing issues with imperative relevance to clinicians. The pathogenesis of GI symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 are of particular relevance because they cannot be sufficiently explained from the existing knowledge of the viral diseases. Tissue specific variations of SARS-CoV-2 cell entry related receptors expression in healthy individuals can help in understanding the pathophysiological basis the aforementioned collection of symptoms. Materials and Methods: The data were downloaded from the Human Protein Atlas available at ( https://www.proteinatlas.org/humanproteome/sars-cov-2 ) and the tissue specific expressions (both mRNA and protein) of ACE2 and TMPRSS2 as yielded from the studies with RNA sequencing and immunohistochemistry (IHC) were analyzed as a function of the various components of the digestive tract. A digestive system specific functional enrichment map of ACE2 gene was created using g:profiler ( https://biit.cs.ut.ee/gprofiler/gost ) utility and the data were visualized using Cytoscape software, version 3.7.2 ( https://cytoscape.org/ ). Results: The correlated expression (transcriptomic and proteomic) of ACE2 (to which SARS-CoV-2 binds through the S-spike) was found to be enriched in the lower gastrointestinal tract (GIT) (highest in small intestine, followed by colon and rectum), and was undetectable in the upper GIT components: mouth cavity (tongue, oral mucosa, and salivary glands), esophagus, and stomach. High expression of ACE2 was noted in the glandular cells as well as in the enterocytes in the lining epithelium (including brush border epithelium). Among other digestive system organs, Gall bladder (GB) showed high expression of ACE2 in glandular cells, while any protein expression was undetectable in liver and pancreas. TMPRSS2 was found enhanced in GIT and exocrine glands of pancreas, and co-localized with ACE2 in enterocytes. Conclusions: Based on the findings of this study and supportive evidence from the literature we propose that a SARS-CoV-2 binding with ACE2 mediates dysregulation of the sodium dependent nutrient transporters and hence may be a plausible basis for the digestive symptoms in COVID-19 patients. ACE2 mediated dysregulation of sodium dependent glucose transporter (SGLT1 or SLC5A1) in the intestinal epithelium also links it to the pathogenesis of diabetes mellitus which can be a possible reason for the associated mortality in COVID-19 patients with diabetes. High expression of ACE2 in mucosal cells of the intestine and GB make these organs potential sites for the virus entry and replication. Continued replication of the virus at these ACE2 enriched sites may be a basis for the disease recurrence reported in some, thought to be cured, patients. Graphical